Your enquiry has been submitted
Caffeic Acid Ferric Citrate Test Agar (CAFC Medium)
Cryptococcus#CC293D
Intended Use
Recommended for selective isolation and presumptive identification of Cryptococcus neoformans and its differentiation from other species.
Composition**
| Ingredients | g/L |
|---|---|
| Yeast extract | 2.000 |
| Dextrose (Glucose) | 5.000 |
| Ammonium sulphate | 5.000 |
| Dipotassium hydrogen phosphate | 0.800 |
| Magnesium sulphate | 0.700 |
| Caffeic acid | 0.180 |
| Ferric citrate | 0.020 |
| Agar | 20.000 |
Final pH (at 25°C): 6.5±0.2
**Formula adjusted, standardized to suit performance parameters
Directions
Suspend 33.7 grams in 1000 ml purified/distilled water. Heat to boiling to dissolve the medium completely. Sterilize by autoclaving at 15 lbs pressure (121°C) for 15 minutes. Cool to 45-50°C. If desired aseptically add sterile solution of Chloramphenicol to yield a final concentration of 50 mcg/ml medium. Mix well and pour into sterile Petri plates.
Principle And Interpretation
Cryptococcus neoformans is an encapsulated basidiomycete yeast-like fungus. C. neoformans have affinity for avian habitats and has been isolated from soil contaminated by bird droppings (1). It causes diseases in apparently immunocompetants, as well as immunocompromised hosts (2). The most susceptible are patients with T-Cell deficiencies (2). C. neoformans is the fourth most common cause of life-threatening infection in patients with AIDS (1).
Caffeic Acid Ferric Citrate Test Agar is used for the rapid identification and differentiation of C. neoformans from other species of Cryptococcus. This medium was described by Hopfer and Blank (3). The medium contains caffeic acid which is a selective agent for C. neoformans. Caffeic acid is an O-diphenol compound which can be oxidized by phenoloxidase enzyme to produce dark brown melanin pigmentation. C. neoformans has a unique ability to produce melanin or melanin-like pigment from p- and o-diphenols (4,5) and can be differentiated from Candida albicans (6). Thus, Caffeic acid causes pigment production of C. neoformans in the presence of (iron) ferric citrate (7).
Dextrose is the fermentable carbohydrate in the medium while yeast extract serves as the source of nitrogenous nutrients and B vitamins. Sulphates and phosphate buffer the medium. Ferric citrate aids in pigment production by C. neoformans in the presence of caffeic acid. Chloramphenicol, if added, inhibits the accompanying bacterial flora.
Growth of C. neoformans on this medium should be compared with same organism on another medium before inoculation to see whether colonial growth is naturally pigmented. False negative reactions may occur. Pigment production is delayed during luxurious growth. Other Cryptococci may become pigmented after 3-4 days of inoculation, but they are not so intensely coloured and can therefore be distinguished from C. neoformans (3).
Type of specimen
Clinical samples - Tissue or body fluid, sputum samples
Specimen Collection and Handling:
For clinical samples follow appropriate techniques for handling specimens as per established guidelines (8,9). After use, contaminated materials must be sterilized by autoclaving before discarding.
Warning and Precautions :
In Vitro diagnostic Use only. For professional use only. Read the label before opening the container. Wear protective gloves/protective clothing/eye protection/ face protection. Follow good microbiological lab practices while handling specimens and culture. Standard precautions as per established guidelines should be followed while handling clinical specimens. Safety guidelines may be referred in individual safety data sheets.
Limitations :
- Growth of C. neoformans on this medium should be compared with same organism on another medium before inoculation to see whether colonial growth is naturally pigmented.
- Pigment production is delayed during luxurious growth.
Performance and Evaluation
Performance of the medium is expected when used as per the direction on the label within the expiry period when stored at recommended temperature.
Quality Control
Appearance
Cream to yellow homogeneous free flowing powder
Gelling
Firm,comparable with 2.0% agar gel.
Colour and Clarity of prepared medium
Medium amber with purple tinge clear to slightly opalescent gel forms in Petri plates
Reaction
Reaction of 3.37% w/v aqueous solution at 25°C. pH: 6.5±0.2
pH
6.30-6.70
Cultural Response
Cultural characteristics observed with added 50 mcg/ml Chloramphenicol after an incubation at 25-30°C for 24-48 hours.
| Organism | Growth | Colour of colony |
|---|---|---|
| Candida albicans ATCC 10231 (00054*) | good | white |
| Cryptococcus neoformans ATCC 32045 | good | brown |
| Escherichia coli ATCC 25922 (00013*) | inhibited | |
| Staphylococcus aureus subsp. aureus ATCC 25923 (00034*) | inhibited |
Key: *Corresponding WDCM numbers.
Storage and Shelf Life
Store between 10-30°C in a tightly closed container and the prepared medium at 15-30°C. Use before expiry date on the label. On opening, product should be properly stored dry, after tightly capping the bottle in order to prevent lump formation due to the hygroscopic nature of the product. Improper storage of the product may lead to lump formation. Store in dry ventilated area protected from extremes of temperature and sources of ignition Seal the container tightly after use. Product performance is best if used within stated expiry period.
Disposal
User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow established laboratory procedures in disposing of infectious materials and material that comes into contact with clinical sample must be decontaminated and disposed of in accordance with current laboratory techniques (8,9).
Reference
- Taylor R. L. and Duangmani C., 1968, Am. J. Epidemiol., 87 (2): 318
- Mitchell T. G., Perdect J. R., 1995, 8: 515
- Hopfer R. L. and Blank F., 1975, J. Clin. Microbiol., 2 (2):115.
- Chaskes S. and Tyndall R., 1975, J. Clin. Microbiol., 1(6):509.
- MacFaddin J. F., 1985, Media for Isolation-Cultivation-Identification-Maintenance of Medical Bacteria, Vol. I, Williams and Wilkins, Baltimore.
- Korth H. and Pulverer G., 1971, Appl. Microbiol., 21:541.
- Pulverer G. and Korth H., 1971, Med. Microbiol. Immunol., 157, 46.
- Isenberg, H.D. Clinical Microbiology Procedures Handbook 2nd Edition.
- Jorgensen, J.H., Pfaller, M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015) Manual of Clinical Microbiology, 11th Edition. Vol. 1.
| Product Name | Caffeic Acid Ferric Citrate Test Agar (CAFC Medium) |
|---|---|
| SKU | M563 |
| Product Type | Regular |
| Physical Form | Powder |
| Origin | Animal Free (Microbial) |
| Packaging type | HDPE |
| References | 1. Taylor R. L. and Duangmani C., 1968, Am. J. Epidemiol., 87 (2): 318 2.Hopfer R. L. and Blank F., 1975, J. Clin. Microbiol., 2 (2):115. 3.Chaskes S. and Tyndall R., 1975, J. Clin. Microbiol., 1(6):509. 4.MacFaddin J. F., 1985, Media for Isolation-Cultivation-Identification-Maintenance of Medical Bacteria, Vol. I, Williamsand Wilkins, Baltimore. 5.Korth H. and Pulverer G., 1971, Appl. Microbiol., 21:541. 6.Pulverer G. and Korth H., 1971, Med. Microbiol. Immunol., 157, 46. 7.Mitchell T. G., Perdect J. R., 1995, 8: 515 |
| Customized Product Available | No |




